Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

The cuts have hit most of the eight minority health offices across HHS, in many cases laying off the majority of workers, if ...